Orbimed Advisors LLC Cabaletta Bio, Inc. Transaction History

Orbimed Advisors LLC

  • $3.21 Billion
  • Q1 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.99 - $2.11 $571,733 - $1.22 Million
-577,509 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$1.68 - $3.92 $462,000 - $1.08 Million
275,000 Added 90.91%
577,509 $1.17 Million
Q3 2021

Nov 15, 2021
BUY
$7.0 - $12.5 $2.12 Million - $3.78 Million
302,509 New
302,509 $3.68 Million

Others Institutions Holding CABA

# of Institutions
91
Shares Held
41.5M
Call Options Held
154K
Put Options Held
192K
View Full List

About Cabaletta Bio, Inc.

CABA Quotes by TradingView
  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $39.5M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email